Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anne L Bishop & Andrew Camilli. (2011) Vibrio cholerae: lessons for mucosal vaccine design. Expert Review of Vaccines 10:1, pages 79-94.
Read now
Read now
Ajaz A. Bhat, Ratnesh K. Seth, Sudhir Kumar, Riyasat Ali, Teena Mohan, Sukla Biswas & D. N. Rao. (2010) Induction of Cell-Mediated Immune Responses to Peptide Antigens of P. vivax in Microparticles Using Intranasal Immunization. Immunological Investigations 39:4-5, pages 483-499.
Read now
Read now
Articles from other publishers (12)
Hellfritzsch & Scherließ. (2019) Mucosal Vaccination via the Respiratory Tract. Pharmaceutics 11:8, pages 375.
Crossref
Crossref
Regina Scherließ, Mathias Mönckedieck, Katherine Young, Sabrina Trows, Simon Buske & Sarah Hook. (2015) First in vivo evaluation of particulate nasal dry powder vaccine formulations containing ovalbumin in mice. International Journal of Pharmaceutics 479:2, pages 408-415.
Crossref
Crossref
Regina Scherließ. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
287
306
.
Anne L. Bishop, Stefan Schild, Bharathi Patimalla, Brian Klein & Andrew Camilli. (2010)
Mucosal Immunization with
Vibrio cholerae
Outer Membrane Vesicles Provides Maternal Protection Mediated by Antilipopolysaccharide Antibodies That Inhibit Bacterial Motility
. Infection and Immunity 78:10, pages 4402-4420.
Crossref
Crossref
Ajaz A. Bhat, Ratnesh K. Seth, Jayaprakash Babu, Sukla Biswas & D.N. Rao. (2009) Induction of mucosal and systemic humoral immune responses in murine system by intranasal immunization with peptide antigens of P. vivax and CpG oligodeoxynucleotide (ODN) in microparticle delivery. International Immunopharmacology 9:10, pages 1197-1208.
Crossref
Crossref
Johan Holst, Diana Martin, Richard Arnold, Concepcion Campa Huergo, Philipp Oster, Jane O’Hallahan & Einar Rosenqvist. (2009) Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27, pages B3-B12.
Crossref
Crossref
Richard Malley, Amit Srivastava, Marc Lipsitch, Claudette M. Thompson, Claire Watkins, Arthur Tzianabos & Porter W. Anderson. (2006) Antibody-Independent, Interleukin-17A-Mediated, Cross-Serotype Immunity to Pneumococci in Mice Immunized Intranasally with the Cell Wall Polysaccharide. Infection and Immunity 74:4, pages 2187-2195.
Crossref
Crossref
H. Bakke, H. H. Samdal, J. Holst, F. Oftung, I. L. Haugen, A.-C. Kristoffersen, A. Haugan, L. Janakova, G. E. Korsvold, G. Krogh, E. A. S. Andersen, P. Djupesland, T. Holand, R. Rappuoli & B. Haneberg. (2006) Oral Spray Immunization May Be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies but not Nasal Mucosal or Cellular Immunity. Scandinavian Journal of Immunology 63:3, pages 223-231.
Crossref
Crossref
Samir Mitragotri. (2005) Immunization without needles. Nature Reviews Immunology 5:12, pages 905-916.
Crossref
Crossref
Tetsuya Harakuni, Hideki Sugawa, Ai Komesu, Masayuki Tadano & Takeshi Arakawa. (2005) Heteropentameric Cholera Toxin B Subunit Chimeric Molecules Genetically Fused to a Vaccine Antigen Induce Systemic and Mucosal Immune Responses: a Potential New Strategy To Target Recombinant Vaccine Antigens to Mucosal Immune Systems. Infection and Immunity 73:9, pages 5654-5665.
Crossref
Crossref
G. Bizanov, L. Janakova, S.-E. Knapstad, T. Karlstad, H. Bakke, I. L. Haugen, A. Haugan, H. H. Samdal & B. Haneberg. (2005) Immunoglobulin-A antibodies in Upper Airway Secretions may Inhibit Intranasal Influenza Virus Replication in Mice but not Protect Against Clinical Illness. Scandinavian Journal of Immunology 61:6, pages 503-510.
Crossref
Crossref
Hilde Bakke, Torhild N. Setek, Phuong N. Huynh, Inger Lise Haugen, E.Arne Høiby, Johan Holst, Ingeborg S. Aaberge & Bjørn Haneberg. (2004) Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory. Vaccine 22:17-18, pages 2278-2284.
Crossref
Crossref